Company Directory > Pharma > Export-Import Bank of Korea
The Export-Import Bank of Korea (KEXIM) is the official export credit agency of South Korea, established in 1976. It operates under the Ministry of Economy and Finance and is tasked with facilitating the development of the Korean economy and enhancing economic cooperation with foreign countries. The bank provides comprehensive financial support for export/import transactions, overseas investment projects, and the development of natural resources, often serving as a bridge between the Korean government and international markets. In recent years, KEXIM has shifted its strategic focus toward 'K-Bio' and other high-tech industries, providing massive funding to support the global expansion of Korean pharmaceutical and biotech firms. It manages several government-entrusted funds, including the Economic Development Cooperation Fund (EDCF) and the Inter-Korean Cooperation Fund (IKCF), and has recently launched a major Bio-healthcare-KFund to drive innovation in immunotherapy and medical devices.
CLASSIFICATION
Company Type:Pharma
Industry:Banking
Sub-Industry:Export Credit Agency / Development Finance
SIZE & FINANCIALS
Employees:501-1000
Revenue:$1B-$5B
Founded:1976
Ownership:government
Status:operating
FUNDING
Stage:Government Backed
Total Raised:$100B+
Investors:Ministry of Economy and Finance (Korea), The Bank of Korea, Korea Development Bank
STOCK
Exchange:BMV
Ticker:KEXIM
PIPELINE
Stage:Commercial
Lead Drug Stage:Not Applicable (Financial Institution)
Modalities:Small molecule, mAb, ADC, Cell therapy, Vaccines
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Republic of Korea
Subsidiaries:KEXIM Global (Singapore) Ltd., Kexim Asia Limited (Hong Kong), KEXIM Indonesia Finance, Kexim Bank UK
Key Partnerships:Korea Health Industry Development Institute (KHIDI) - Global expansion of healthcare, Inter-American Development Bank (IDB) - Infrastructure and health system co-financing, Japan Bank for International Cooperation (JBIC) - Green and supply chain cooperation, Celltrion - Financing for US manufacturing facility acquisition
COMPETITION
Position:Leader
Competitors:Korea Trade Insurance Corporation (K-SURE), Korea Development Bank (KDB), China Exim Bank, JBIC (Japan), EXIM Bank of the United States
LEADERSHIP
Key Executives:
Hwang Ki-yeon - Chairman & CEO
Kim Jin-seop - Head of Planning & Management
Lee Dong-hoon - Head of SME & Mid-sized Business Finance
Board Members:Hwang Ki-yeon, Ahn Jong-hyuk, Lee Dong-hoon
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Export-Import Bank of Korea. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.